US equities
|
INTC
$65.62
▼-28.73%
AMZN
$236.08
▼-3.16%
MU
$887.03
▼-5.06%
NVDA
$206.00
▼-3.59%
SNDK
$1,187.73
▼-10.70%
GOOGL
$279.94
▼-1.37%
AMD
$510.76
▼-9.83%
TSLA
$396.93
▼-1.58%
INTC
$65.62
▼-28.73%
AMZN
$236.08
▼-3.16%
MU
$887.03
▼-5.06%
NVDA
$206.00
▼-3.59%
SNDK
$1,187.73
▼-10.70%
GOOGL
$279.94
▼-1.37%
AMD
$510.76
▼-9.83%
TSLA
$396.93
▼-1.58%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
(TSV:
MRVL
)
0.1200
UNCHANGED
Delayed Quote
Updated: 9:43 AM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MRVL
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
November 15, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Marvel Biosciences Corp. to Present at the Life Sciences Investor Forum November 14th
November 13, 2024
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Biotech Sector Working Fast to Combat Alzheimer’s Disease Cases That are Set to Explode
March 15, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 15, 2023 – USA News Group – According to a 2022 study of more than 6 million patients 65 and older, the risk factor for...
Via
FinancialNewsMedia
Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates
November 14, 2022
EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Retirement
Marvel Biosciences Announces Stock Option Grants
September 26, 2022
Calgary, Alberta--(Newsfile Corp. - September 26, 2022) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology...
Via
Newsfile
Marvel Biosciences to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
December 03, 2021
CALGARY, AB / ACCESSWIRE / December 3, 2021 / Marvel Biosciences (TSXV:MRVL), and its wholly owned subsidiary, Marvel Biotechnology Inc., today announced that it will be presenting at the SNN Network...
From
Marvel Biosciences
Via
AccessWire
Topics
Derivatives
Intellectual Property
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will...
From
Stock News Now
Via
AccessWire
